The FDA approved a new nasal spray as a rapid treatment for migraine pain in adults.
WASHINGTON — The U.S. Food and Drug Administration approved a new nasal spray as a rapid treatment for migraine pain in adults.
There are already a number of different types of medications available to treat migraines, including several kinds of nasal sprays. Zavzpret is the first to work by blocking the calcitonin gene-related peptide, CGRP, a protein that is released in the brain that contributes to inflammation. Several pills block CGRP, but many people with migraines experience significant nausea and can't tolerate medications they have to swallow.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
New ‘Fast-Acting’ Migraine Drug Approved By FDAPfizer’s nasal spray drug can provide migraine pain relief in as little as 15 minutes, clinical trials suggest.
Leer más »
Mexican Sinaloa drug cartel operative pleads guilty to international drug trafficking chargesA man who coordinated cocaine shipments out of Colombia and into the hands of Mexico's Sinaloa drug cartel for distribution in the U.S. has pleaded guilty to drug trafficking charges.
Leer más »
Utah Food Bank expects increased demand as boost to food stamps endsThe Utah Food Bank is gearing up for more demand for assistance after boosted food stamp benefits ended in February.
Leer más »
FDA approves new nasal spray to treat migraine headaches in adults, Pfizer says | CNNThe FDA has approved a new nasal spray as a rapid treatment for migraine pain in adults. The spray may relieve pain and other migraine symptoms as soon as 15 minutes after use, drugmaker Pfizer says.
Leer más »
FDA Approves Amphastar Pharma's Nasal Spray for Opioid OverdoseAmphastar Pharmaceuticals Inc said on Wednesday the FDA had approved its nasal spray for emergency treatment of known or suspected opioid overdose.
Leer más »
Pfizer wins FDA approval for its migraine nasal sprayPfizer Inc. said Friday the U.S. Food and Drug Administration has approved its migraine nasal spray Zavzpret. The treatment is the first and only calcitonin...
Leer más »